461 related articles for article (PubMed ID: 20091495)
1. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
Simsek I; Kaya A; Erdem H; Pay S; Yenicesu M; Dinc A
J Nephrol; 2010; 23(1):119-23. PubMed ID: 20091495
[TBL] [Abstract][Full Text] [Related]
2. Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.
Drewe E; Huggins ML; Morgan AG; Cassidy MJ; Powell RJ
Rheumatology (Oxford); 2004 Nov; 43(11):1405-8. PubMed ID: 15316120
[TBL] [Abstract][Full Text] [Related]
3. Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome.
Drewe E; McDermott EM; Powell RJ
N Engl J Med; 2000 Oct; 343(14):1044-5. PubMed ID: 11023397
[No Abstract] [Full Text] [Related]
4. Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis.
Smith GR; Tymms KE; Falk M
Intern Med J; 2004; 34(9-10):570-2. PubMed ID: 15482271
[TBL] [Abstract][Full Text] [Related]
5. Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis.
Kuroda T; Wada Y; Kobayashi D; Murakami S; Sakai T; Hirose S; Tanabe N; Saeki T; Nakano M; Narita I
J Rheumatol; 2009 Nov; 36(11):2409-15. PubMed ID: 19797512
[TBL] [Abstract][Full Text] [Related]
6. [Familial Mediterranean fever with amyloidosis. Recent pathogenetic and therapeutic aspects].
Löffler HJ; Brass H; Thoenes W; Linke RP
Dtsch Med Wochenschr; 1983 Feb; 108(6):210-5. PubMed ID: 6825596
[TBL] [Abstract][Full Text] [Related]
7. Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis.
Kallinich T; Briese S; Roesler J; Rudolph B; Sarioglu N; Blankenstein O; Keitzer R; Querfeld U; Haffner D
J Rheumatol; 2004 Dec; 31(12):2519-22. PubMed ID: 15570662
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.
Gottenberg JE; Merle-Vincent F; Bentaberry F; Allanore Y; Berenbaum F; Fautrel B; Combe B; Durbach A; Sibilia J; Dougados M; Mariette X
Arthritis Rheum; 2003 Jul; 48(7):2019-24. PubMed ID: 12847696
[TBL] [Abstract][Full Text] [Related]
9. AA type renal amyloidosis secondary to FMF: a long-term follow-up in two patients.
Aybal Kutlugün A; Yildirim T; Altindal M; Arici M; Yasavul U; Turgan C
Ren Fail; 2010; 32(10):1230-2. PubMed ID: 20954987
[TBL] [Abstract][Full Text] [Related]
10. [Systemic AA amyloidosis induced by benign neoplasms].
Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
[TBL] [Abstract][Full Text] [Related]
11. From renal amyloid deposits to the identification of the culprit genes.
Pirson Y
J Nephrol; 2003; 16(3):427-30. PubMed ID: 12832746
[TBL] [Abstract][Full Text] [Related]
12. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
13. [Nephrotic syndrome in familial Mediterranean fever--effect of colchicine therapy].
Højberg AS; Mertz H
Ugeskr Laeger; 1995 Jul; 157(28):4035-7. PubMed ID: 7645081
[TBL] [Abstract][Full Text] [Related]
14. Familial Mediterranean fever successfully treated with etanercept.
Mor A; Pillinger MH; Kishimoto M; Abeles AM; Livneh A
J Clin Rheumatol; 2007 Feb; 13(1):38-40. PubMed ID: 17278949
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with cyclophosphamide and prednisolone can induce remission of nephrotic syndrome in a patient with renal amyloidosis, associated with rheumatoid arthritis.
Maezawa A; Hiromura K; Mitsuhashi H; Tsukada Y; Kanai H; Yano S; Naruse T
Clin Nephrol; 1994 Jul; 42(1):30-2. PubMed ID: 7923963
[TBL] [Abstract][Full Text] [Related]
16. Cardiac and intestinal amyloidosis in a renal transplant recipient with familial Mediterranean fever.
Yildiz A; Akkaya V; Kiliçaslan I; Türkmen A; Görçin B; Atilgan D; Sever MS
J Nephrol; 2001; 14(2):125-7. PubMed ID: 11411014
[TBL] [Abstract][Full Text] [Related]
17. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.
Nowlan ML; Drewe E; Bulsara H; Esposito N; Robins RA; Tighe PJ; Powell RJ; Todd I
Rheumatology (Oxford); 2006 Jan; 45(1):31-7. PubMed ID: 16287931
[TBL] [Abstract][Full Text] [Related]
18. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
[TBL] [Abstract][Full Text] [Related]
19. Remission of nephrotic syndrome due to AA-amyloidosis, complicating familiar Mediterranean fever, with tocilizumab.
Serelis J; Christaki S; Skopouli FN
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S169. PubMed ID: 25572486
[No Abstract] [Full Text] [Related]
20. Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor.
Agha I; Mahoney R; Beardslee M; Liapis H; Cowart RG; Juknevicius I
Am J Kidney Dis; 2002 Aug; 40(2):411-5. PubMed ID: 12148117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
